Ignite Creation Date:
2025-12-25 @ 3:43 AM
Ignite Modification Date:
2025-12-26 @ 2:29 AM
Study NCT ID:
NCT04503902
Status:
UNKNOWN
Last Update Posted:
2022-11-29
First Post:
2020-08-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma
Sponsor:
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
JS001D-C-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None